Meeder Asset Management Inc Eagle Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $158 - $282	6 Added 9.38%	70 $2,000
Q2 2022 Aug 08, 2022	SELL	$41.26 - $51.35 $536 - $667	-13 Reduced 16.88%	64 $3,000
Q1 2022 May 10, 2022	BUY	$44.58 - $52.6 $3,432 - $4,050	77 New	77 $4,000
Q4 2021 Feb 11, 2022	SELL	$45.82 - $56.9 $1,557 - $1,934	-34 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$43.79 - $55.78 $744 - $948	17 Added 100.0%	34 $2,000
Q2 2021 Aug 09, 2021	SELL	$36.86 - $44.5 $516 - $623	-14 Reduced 45.16%	17 $1,000
Q1 2021 Apr 28, 2021	SELL	$40.32 - $50.97 $846 - $1,070	-21 Reduced 40.38%	31 $1,000
Q4 2020 Feb 09, 2021	BUY	$41.72 - $51.34 $417 - $513	10 Added 23.81%	52 $2,000
Q3 2020 Nov 02, 2020	BUY	$37.02 - $51.28 $1,258 - $1,743	34 Added 425.0%	42 $2,000
Q2 2020 Aug 11, 2020	BUY	$43.24 - $55.02 $345 - $440	8 New	8 $0
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $25,468 - $44,511	-741 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$54.32 - $64.31 $28,192 - $33,376	519 Added 233.78%	741 $44,000
Q3 2019 Oct 17, 2019	BUY	$53.25 - $59.98 $9,638 - $10,856	181 Added 441.46%	222 $12,000
Q2 2019 Aug 05, 2019	BUY	$46.61 - $58.45 $1,911 - $2,396	41 New	41 $2,000
Q4 2018 Jan 17, 2019	SELL	$36.72 - $67.73 $77,001 - $142,029	-2,097 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$66.65 - $83.86 $15,396 - $19,371	231 Added 12.38%	2,097 $0
Q2 2018 Jul 24, 2018	BUY	$51.25 - $76.62 $66,881 - $99,989	1,305 Added 232.62%	1,866 $0
Q1 2018 May 03, 2018	BUY	$52.16 - $66.86 $19,768 - $25,339	379 Added 208.24%	561 $30,000
Q4 2017 Feb 02, 2018	SELL	$49.6 - $60.87 $32,736 - $40,174	-660 Reduced 78.38%	182 $9,000
Q3 2017 Oct 20, 2017	BUY	$46.62 - $60.36 $39,254 - $50,823	842	842 $50,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account